Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Ramipril
Total, all-cause mortality	Candesartan Cilexetil
Total, all-cause mortality	Ramipril and Allopurinol
Total, all-cause mortality	Candesartan Cilexetil and Allopurinol
Total, other adverse events	Ramipril	3	18
Total, other adverse events	Candesartan Cilexetil	4	18
Total, other adverse events	Ramipril and Allopurinol	6	18
Total, other adverse events	Candesartan Cilexetil and Allopurinol	3	18
Total, serious adverse events	Ramipril	4	18
Total, serious adverse events	Candesartan Cilexetil	6	18
Total, serious adverse events	Ramipril and Allopurinol	9	18
Total, serious adverse events	Candesartan Cilexetil and Allopurinol	5	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01052272/event-totals